Related Experiment Videos
Airway structural alterations selectively associated with severe asthma.
Laurent Benayoun1, Anne Druilhe, Marie-Christine Dombret
1Institut National de la Santé et de la Recherche Médicale Unité 408, Faculté de Médecine Xavier Bichat, Service de Pneumologie, Hôpital Bichat, Paris, France.
American Journal of Respiratory and Critical Care Medicine
|January 18, 2003
Summary
Fibroblast accumulation and airway smooth muscle (ASM) hypertrophy in airways are key indicators of severe asthma, not inflammation or basement membrane thickness. These findings help identify severe persistent asthma. Keywords: severe asthma, airway smooth muscle, fibroblast, hypertrophy.
Area of Science:
- Pulmonary Medicine
- Respiratory Pathology
- Asthma Research
Background:
- Asthma severity is complex and influenced by various airway remodeling processes.
- Identifying specific pathological markers associated with severe asthma is crucial for targeted therapies.
- Distinguishing severe asthma from other obstructive lung diseases like COPD is clinically important.
Purpose of the Study:
- To identify airway pathologic abnormalities selectively associated with severe persistent asthma.
- To differentiate severe asthma from milder asthma and chronic obstructive pulmonary disease (COPD) based on airway histology.
- To investigate the relationship between specific cellular and structural changes and lung function (FEV1).
Main Methods:
- Bronchial biopsies were analyzed from control subjects and patients with intermittent, mild-to-moderate persistent, and severe persistent asthma, as well as COPD.
- Histological assessments included epithelial integrity, subepithelial basement membrane (SBM) thickness, collagen type III deposition, inflammatory cell counts (eosinophils, neutrophils), fibroblast numbers, mucous gland area, airway smooth muscle (ASM) area, SBM-ASM distance, and ASM hypertrophy.
- Expression of contractile proteins and signaling molecules in ASM was evaluated.
Main Results:
- Epithelial damage, SBM thickness, and inflammatory cell counts did not correlate with asthma severity.
- Severe persistent asthma was characterized by increased fibroblast numbers, collagen type III deposition, larger mucous gland and ASM areas, augmented ASM cell size (hypertrophy), and increased myosin light-chain kinase expression.
- Fibroblast numbers and ASM cell size were negatively associated with FEV1 values in asthma patients.
Conclusions:
- Fibroblast accumulation and ASM hypertrophy in proximal airways are selective determinants of severe persistent asthma.
- These structural changes, rather than inflammation or basement membrane thickening, are key pathological features distinguishing severe asthma.
- Targeting fibroblast proliferation and ASM remodeling may offer therapeutic strategies for severe asthma.